Screener
Pulmonx Corporation LUNG EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Pulmonx Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001127537-26-000025
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss | (13,654) | (14,448) |
| Other comprehensive (loss) income | ||
| Currency translation adjustment | (191) | 111 |
| Change in unrealized losses on marketable securities | — | (22) |
| Total other comprehensive (loss) income | (191) | 89 |
| Comprehensive loss | $(13,845) | $(14,359) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.33) | $(0.36) |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | 41,897,669 | 39,954,658 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Pulmonx Corporation's EPS (diluted)?
- Pulmonx Corporation (LUNG) reported EPS (diluted) of -$0.33 in Q1 2026.
- How has Pulmonx Corporation's EPS (diluted) changed year-over-year?
- Pulmonx Corporation's EPS (diluted) increased by 8.3% year-over-year, from -$0.36 to -$0.33.
- What is the long-term trend for Pulmonx Corporation's EPS (diluted)?
- Over 4 years (2021 to 2025), Pulmonx Corporation's EPS (diluted) has grown at a -0.4% compound annual growth rate (CAGR), from -$1.35 to -$1.33.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Pulmonx Corporation's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude